SE8306367L - Antidiuretiskt verkande farmaceutiskt preparat - Google Patents

Antidiuretiskt verkande farmaceutiskt preparat

Info

Publication number
SE8306367L
SE8306367L SE8306367A SE8306367A SE8306367L SE 8306367 L SE8306367 L SE 8306367L SE 8306367 A SE8306367 A SE 8306367A SE 8306367 A SE8306367 A SE 8306367A SE 8306367 L SE8306367 L SE 8306367L
Authority
SE
Sweden
Prior art keywords
ddavp
composition
antidiuretically
absorbed
human
Prior art date
Application number
SE8306367A
Other languages
English (en)
Swedish (sv)
Other versions
SE8306367D0 (sv
Inventor
E H Hagstam
H Vilhardt
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20353381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8306367(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8306367A priority Critical patent/SE8306367L/xx
Publication of SE8306367D0 publication Critical patent/SE8306367D0/xx
Priority to PCT/US1984/001860 priority patent/WO1985002119A1/fr
Priority to AT85900287T priority patent/ATE52187T1/de
Priority to KR1019850700128A priority patent/KR930003332B1/ko
Priority to AU36734/84A priority patent/AU577338B2/en
Priority to EP85900287A priority patent/EP0163723B1/fr
Priority to IL73523A priority patent/IL73523A/xx
Priority to DE8585900287T priority patent/DE3482028D1/de
Priority to DK546284A priority patent/DK168515B1/da
Priority to ZA848965A priority patent/ZA848965B/xx
Priority to CA000467991A priority patent/CA1232839A/fr
Priority to IE2951/84A priority patent/IE57989B1/en
Priority to BE0/214019A priority patent/BE901073A/fr
Priority to PT79513A priority patent/PT79513B/pt
Priority to IT8409544A priority patent/IT1206233B/it
Priority to FI844540A priority patent/FI844540L/fi
Priority to NZ210245A priority patent/NZ210245A/xx
Priority to IN902/MAS/84A priority patent/IN159607B/en
Publication of SE8306367L publication Critical patent/SE8306367L/xx
Priority to OA58645A priority patent/OA08164A/xx
Priority to US06/809,937 priority patent/US5047398A/en
Priority to HK76091A priority patent/HK76091A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
SE8306367A 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat SE8306367L (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE8306367A SE8306367L (sv) 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat
PCT/US1984/001860 WO1985002119A1 (fr) 1983-11-18 1984-11-15 Ddavp antidiuretique et son procede d'utilisation
AT85900287T ATE52187T1 (de) 1983-11-18 1984-11-15 Ddavp-antidiuretisches mittel und dessen verwendung.
KR1019850700128A KR930003332B1 (ko) 1983-11-18 1984-11-15 항이뇨제 ddavp의 경구 투여용 제제의 제조방법
AU36734/84A AU577338B2 (en) 1983-11-18 1984-11-15 Ddavp antidiuretic and method therefor
EP85900287A EP0163723B1 (fr) 1983-11-18 1984-11-15 Ddavp antidiuretique et son procede d'utilisation
IL73523A IL73523A (en) 1983-11-18 1984-11-15 Antidiuretic compositions containing a vasopressin derivative
DE8585900287T DE3482028D1 (de) 1983-11-18 1984-11-15 Ddavp-antidiuretisches mittel und dessen verwendung.
PT79513A PT79513B (en) 1983-11-18 1984-11-16 Process for the preparation of antidiuretics containing 1-desamino-8-arginine-vasopressine (ddavp)
ZA848965A ZA848965B (en) 1983-11-18 1984-11-16 Ddavp antidiuretic and method therefor
BE0/214019A BE901073A (fr) 1983-11-18 1984-11-16 Composition antidiuretique a usage oral.
DK546284A DK168515B1 (da) 1983-11-18 1984-11-16 Antidiuretisk middel
CA000467991A CA1232839A (fr) 1983-11-18 1984-11-16 Ddavp antidiuretique et methode d'application
IE2951/84A IE57989B1 (en) 1983-11-18 1984-11-16 Ddavp antidiuretic and method therefor
IT8409544A IT1206233B (it) 1983-11-18 1984-11-19 Composto antidiuretico in specie abase di ddavp e relativo metodo di somministrazione
FI844540A FI844540L (fi) 1983-11-18 1984-11-19 Foerfarande foer framstaellning av ett antidiuretiskt preparat.
NZ210245A NZ210245A (en) 1983-11-18 1984-11-19 Antidiuretic composition of vasopressin derivatives
IN902/MAS/84A IN159607B (fr) 1983-11-18 1984-11-21
OA58645A OA08164A (en) 1983-11-18 1985-07-18 Ddavp antidiuretic and method therefor.
US06/809,937 US5047398A (en) 1983-11-18 1985-12-17 DDAVP antidiuretic and method therefor
HK76091A HK76091A (en) 1983-11-18 1991-09-26 Ddavp antidiuretic and method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8306367A SE8306367L (sv) 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat

Publications (2)

Publication Number Publication Date
SE8306367D0 SE8306367D0 (sv) 1983-11-18
SE8306367L true SE8306367L (sv) 1985-05-19

Family

ID=20353381

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306367A SE8306367L (sv) 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat

Country Status (19)

Country Link
US (1) US5047398A (fr)
EP (1) EP0163723B1 (fr)
KR (1) KR930003332B1 (fr)
AU (1) AU577338B2 (fr)
BE (1) BE901073A (fr)
CA (1) CA1232839A (fr)
DE (1) DE3482028D1 (fr)
DK (1) DK168515B1 (fr)
FI (1) FI844540L (fr)
IE (1) IE57989B1 (fr)
IL (1) IL73523A (fr)
IN (1) IN159607B (fr)
IT (1) IT1206233B (fr)
NZ (1) NZ210245A (fr)
OA (1) OA08164A (fr)
PT (1) PT79513B (fr)
SE (1) SE8306367L (fr)
WO (1) WO1985002119A1 (fr)
ZA (1) ZA848965B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
US5350766A (en) * 1992-12-18 1994-09-27 New York Medical College Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
WO1995001368A1 (fr) * 1993-06-29 1995-01-12 Ferring B.V. Synthese amelioree de peptides cycliques
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP1473029B1 (fr) * 2003-04-30 2005-03-23 Ferring B.V. Forme posologique solide de la desmopressine
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ES2243840T3 (es) * 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
EP1530967B1 (fr) * 2003-11-13 2006-05-03 Ferring B.V. Emballage Blister et forme de dosage solide comprenant de la desmopressine
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2988753A1 (fr) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Procedes et dispositifs pour l'administration de medicament desmopressine
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
LT2712622T (lt) 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PL4104848T3 (pl) 2009-06-18 2024-03-25 Acerus Pharmaceuticals USA, LLC Bezpieczne podawanie desmopresyny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids

Also Published As

Publication number Publication date
ZA848965B (en) 1985-10-30
DK546284A (da) 1985-05-19
PT79513A (en) 1984-12-01
IL73523A (en) 1989-02-28
DK546284D0 (da) 1984-11-16
IE57989B1 (en) 1993-06-02
AU3673484A (en) 1985-06-03
IL73523A0 (en) 1985-02-28
FI844540A0 (fi) 1984-11-19
KR850700109A (ko) 1985-10-25
BE901073A (fr) 1985-03-15
DE3482028D1 (de) 1990-05-31
EP0163723A4 (fr) 1986-04-02
IT8409544A0 (it) 1984-11-19
EP0163723A1 (fr) 1985-12-11
US5047398A (en) 1991-09-10
NZ210245A (en) 1989-02-24
FI844540L (fi) 1985-05-19
OA08164A (en) 1987-03-31
IT1206233B (it) 1989-04-14
DK168515B1 (da) 1994-04-11
WO1985002119A1 (fr) 1985-05-23
PT79513B (en) 1986-11-18
IN159607B (fr) 1987-05-30
EP0163723B1 (fr) 1990-04-25
SE8306367D0 (sv) 1983-11-18
CA1232839A (fr) 1988-02-16
IE842951L (en) 1985-05-18
AU577338B2 (en) 1988-09-22
KR930003332B1 (ko) 1993-04-26

Similar Documents

Publication Publication Date Title
SE8306367L (sv) Antidiuretiskt verkande farmaceutiskt preparat
Lam et al. Treatment of duodenal ulcer with antacid and sulpiride: a double-blind controlled study
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ZA963854B (en) Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids.
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
NZ336055A (en) An oral sustained release formulation of opioids
ATE522211T1 (de) Stabilisierte fibrat-mikropartikel
RU2003119545A (ru) Фармацевтические композиции для перорального введения фамакологических действующих веществ
FI963679A0 (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
HK94096A (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
KR920702225A (ko) 약학 조성물
FI89240B (fi) Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet
Burkhart et al. Whole-bowel irrigation as adjunctive treatment for sustained-release theophylline overdose
Maneksha 'Safapryn'and benorylate—a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis
GB8928609D0 (en) Pharmaceutical composition
JPS6360926A (ja) 感冒薬
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
JPS62500866A (ja) 抗利尿剤１−デアミノ−８−ｄ−アルギニン−バソプレッシン及び抗利尿法
SE8304818D0 (sv) A medicine having anti-ulcer, spasmolytic and locally anesthetic effect
JPS57193413A (en) Medicament for alleviating hypercalcemia

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8306367-7

Effective date: 19921222

Format of ref document f/p: F